New

Global ETF Survey Is Live! 600+ ETF Professionals Weigh In. See Results →

Advertisement
Advertisement

ARK Genomic Revolution ETF

This ETF provides exposure to Other Equities

ARKG performance and flow charts

Last update 10/23/2026 at 1:30 PM
Live
Closed
Last price
$48.16
+$0.29 (+0.61%) 10/23/2026

Performance

-10-50510%Sep 23Sep 30Oct 7Oct 14Oct 21

Flows

0 B0.5 B1 B1.5 B2 B
1 day price range
$46.68
$48.21
52 week price range
$24.79
$56.75
1W perf
+3.28%
YTD perf
+65.00%
YTD flows
+$99M
AuM
$2.03B
E/R
0.75%
TTM yield
-
Find out how industry players manage ETF portfolios.  Discover our library of Model portfolios

Historic performance and flows

Data as of October 23, 2026
1M3MYTD1Y3Y5Y
Perf.-5.34%+24.16%+65.00%+53.44%+104.58%-36.03%
Flows-$32M+$52M+$99M+$29M-$398M-$1.99B
Data as of October 23, 2026
Advertisement

Get all the metrics on this page, and more, through a reliable ETF data feed

Daily, global ETF data for advanced analysis or integration into apps (API), from our partner Trackinsight.

Characteristics

This fund is actively managed; it does not track an index. This share class generates a stream of income by distributing dividends.

Management strategyActive
StrategyLong Only
ProviderArk Investment
N° of holdings31
Dividend policyDistributing
Trailing 12m distribution yield
Join for free
Inception dateApril 2, 2019
ESGNo
TrackinsightTrackinsight

More data and info about ARKG on Trackinsight

Exposure

Data as of August 31, 2026

Diversification

74.64%

Total weight of top 15 holdings out of 31

Top 15 Holdings

10X Genomics, Inc.
9.58%
Twist Bioscience Corp.
9.13%
Tempus AI, Inc.
7.91%
CRISPR Therapeutics AG
6.1%
Personalis, Inc.
5.93%
Absci Corp.
4.88%
Natera, Inc.
4.06%
Illumina, Inc.
4.04%
Eli Lilly & Co.
3.86%
CareDx, Inc.
3.85%
Guardant Health, Inc.
3.81%
Beam Therapeutics, Inc.
3.56%
Compass Pathways Plc
3.17%
Recursion Pharmaceuticals, Inc.
2.44%
Adaptive Biotechnologies Corp.
2.32%

Sectors

Healthcare
97.89%
Other
2.11%

Countries

USA
88.62%
Other
11.38%
Advertisement

Trading data

Last sale
10/23/2026 at 1:30 PM
$48.16
Previous close
$47.87
Consolidated volume
10/22/2026
Join for free
Average volume
30 days
Join for free
Average discount or premium
30 days
Join for free
Average Bid/Ask spread
30 days
Join for free

Volatility and drawdown

3M1Y3Y5Y
Volatility+49.20%+44.31%+44.74%+46.82%
Max drawdown
-17.81%-27.52%-46.41%-76.56%
Max drawdown duration
18d126d882d1814d
Time to recover
N/A60d416dN/A
Advertisement
Frequently asked questions about ARKG

What type of ETF is ARKG?

ARKG is a Active ETF that provides exposure to Equity assets. It is managed by Ark Investment.

What does ARKG invest in?

This ETF provides exposure to Other Equities. It is part of the segment: BioTech & Genomics.

What is the expense ratio of ARKG?

The total expense ratio (TER) of ARKG is 0.75%, representing the annual fee charged by the fund manager.

When was ARKG launched?

ARKG was launched on April 2, 2019, marking its entry into the ETF market.

Who is the issuer of ARKG?

ARKG is issued by Ark Investment.

What is the AUM of ARKG?

As of October 23, 2026, ARKG manages $2.03 B, reflecting the total assets held in the fund.

How has ARKG performed recently?

As of October 23, 2026, ARKG delivered a return of -5.34% over the past month (1M performance), 24.16% over the past three months (3M), and 65% year-to-date (YTD).

What are the recent fund flows for ARKG?

As of October 23, 2026, ARKG has seen net flows of -$32M in the past month (1M flow) and +$99M year-to-date (YTD).

How many holdings are in ARKG

As of August 31, 2026, ARKG holds 31 securities in its portfolio. This level of diversification can influence the fund’s risk profile and exposure to individual assets.

How diversified is ARKG?

As of August 31, 2026, ARKG holds 31 securities, with 74.64% of its assets concentrated in its top 15 holdings.

What are the top holdings of ARKG?

As of August 31, 2026, ARKG holds a portfolio of 31 underlyings, with its largest positions including 10X Genomics, Inc., Twist Bioscience Corp. and Tempus AI, Inc.. These top holdings play a significant role in shaping the fund’s performance and exposure.

What countries or regions does ARKG invest in?

As of August 31, 2026, ARKG has its largest geographic exposures in USA.

What sectors or themes does ARKG focus on?

As of August 31, 2026, ARKG is primarily exposed to Healthcare.

The ETF Institute® is now affiliated with ETF Central

The CETF certification is the only FINRA listed professional designation focused on ETFs.

ETF Institute
Advertisement
Advertisement
ETF U
Become a better investor with NYSE: The Home of ETFs
Visit the ETF U homepage
ETF Guides
Advertisement

Recent educational content

ETF Investing Trends - First Look

First Look ETF

First Look ETF: Income, International, and Cash Flow ETFs

In this season 6 episode of First Look ETF, Stephanie Stanton ‪@etfguide‬ examines the latest ETF marketplace trends with NYSE and guests.

ETF Guide
By ETF Guide · October 20, 2026
Tidal ETF Industry KPIs

ETF Trends

ETF Industry KPIs October 5, 2026

This week’s KPI data overview highlights key metrics and trends shaping the ETF landscape.

Tidal
By Tidal · October 6, 2026
Tidal ETF Industry KPIs

ETF Trends

ETF Industry KPIs September 28, 2026

This week’s KPI data overview highlights key metrics and trends shaping the ETF landscape.

Tidal
By Tidal · September 29, 2026
Tidal ETF Industry KPIs

ETF Trends

ETF Industry KPIs September 22, 2026

This week’s KPI data overview highlights key metrics and trends shaping the ETF landscape.

Tidal
By Tidal · September 23, 2026

Browse all educational columns

New Report

ETFs’ Next Act: From Access to Selection

Global ETF Survey 2026